Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+156.7%
5Y CAGR+106.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+156.7%/yr
vs +33.9%/yr prior
5Y CAGR
+106.1%/yr
Recent acceleration
Acceleration
+122.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
37.2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $813.83M | +87.1% |
| 2024 | $435.06M | +302.3% |
| 2023 | $108.15M | +124.7% |
| 2022 | $48.13M | +29.0% |
| 2021 | $37.32M | +70.7% |
| 2020 | $21.86M | -3.5% |
| 2019 | $22.65M | +51.3% |
| 2018 | $14.97M | +95.1% |
| 2017 | $7.67M | -17.4% |
| 2016 | $9.29M | - |